(Press-News.org) In a study that sheds new light on the causes of Parkinson's disease, researchers report that brain cells in Parkinson's patients abandon their energy-producing machinery, the mitochondria. A shutdown in fuel can have devastating effects on brain cells, which consume roughly 20 percent of the body's energy despite making up only 2 percent of body weight.
The findings indicate that boosting the mitochondria with FDA approved drugs early on may prevent or delay the onset of Parkinson's. The study will be published in the one-year anniversary issue of the journal Science Translational Medicine, on Wednesday October 6 2010. Science Translational Medicine is published by AAAS, the nonprofit science society.
Affecting roughly 5 million people worldwide, Parkinson's disease is a relentless condition that starts killing dopamine neurons in the brain many years before the onset of hallmark symptoms like tremors, muscle rigidity and slow movements. Thus, much-needed drugs to slow or halt the disease would have the greatest benefit for patients if they are given early on, before too many dopamine neurons die.
Clemens Scherzer from Brigham and Women's Hospital and Harvard Medical School, along with an international team of researchers, now show that a root cause of Parkinson's disease may lie in 10 gene sets related to energy production that spur neurons in the brain to "divorce" their mitochondria and related energy-producing pathways.
These gene sets are controlled by a master regulator—the PGC-1alpha gene. Moreover, abnormal expression of these genes likely occurs during the initial stages of Parkinson's disease, long before the onset of symptoms, the study shows. Targeting PGC-1alpha may thus be an effective way to slow down or halt the earliest stages of Parkinson's, staving off permanent damage and neuronal loss.
"The most exciting result from our study for me is the discovery of PGC-1alpha as a new therapeutic target for early intervention in Parkinson's disease. PGC-1alpha is a master switch that activates hundreds of mitochondrial genes, including many of those needed to maintain and repair the power plants in the mitochondria," Scherzer said.
FDA-approved medications that activate that PGC-1alpha are already available for widespread diseases like diabetes. These medications may jumpstart the development of new Parkinson's drugs; instead of having to start from scratch, pharmaceutical companies may be able to dust off their drug libraries and find look-alike drugs capable of targeting PGC-1alpha in the brain.
"As we wrap up our first year of publishing the journal, the new study from Zheng et al. exemplifies the goal of Science Translational Medicine, applying knowledge and technology from different fields-such as neuroscience, genomics and bioinformatics-to achieve new discoveries," said Editor Katrina Kelner.
Previous studies have linked defects in mitochondrial activity to Parkinson's disease, but they generally have not provided such a comprehensive, specific set of genes as Scherzer and colleagues now report. The researchers analyzed a part of the brain called the substantia nigra in 185 tissue samples from deceased Parkinson's patients.
The substantia nigra (Latin for "black substance") contains dopamine-producing neurons. Scherzer and colleagues used a laser beam to precisely cut out the dopamine neurons that are abnormal in Parkinson's. Next, the team looked at gene activity in these dopamine neurons and identified gene sets—groups of genes involved in one biological process—that are associated with Parkinson's disease. At the end of this tour-de-force analysis, 10 gene sets linked to Parkinson's emerged. All of these gene sets had a common thread—the master regulator gene PGC-1alpha.
The 10 gene sets encode proteins responsible for cellular processes related to mitochondrial function and energy production. Suppressing these genes is likely to severely damage components required for brain energy metabolism. One of these components is the electron transport chain; a set of reactions controlled by mitochondria that generates the energy cells need to function. Other studies have hinted that one of the five complexes making up the electron transport chain malfunctions in Parkinson's. Yet, Scherzer and colleagues found that not just one, but virtually all of the components needed by mitochondria to build the electron transport chain are deficient.
Why would the brain, being so highly energy dependent, abandon its entire energy-producing apparatus? That seems to be the core mystery of Parkinson's disease. Some think that mitochondrial activity may be affected by a combination of genes and the environment.
"I believe that environmental chemicals, risk genes, and aging—each having a small effect when taken separately—in combination may lead to the pervasive electron transport chain deficit we found in common Parkinson's disease and to which dopamine neurons might be intrinsically more susceptible," said senior author Clemens Scherzer, Assistant Professor of Neurology at Harvard Medical School.
###Science Translational Medicine launched October 7 2009, as new journal in the Science family of journals intended to help speed basic research advances into clinics and hospitals. Serving scientists from academia and industry, as well as doctors, regulators and policy-makers, the journal aims to help researchers more efficiently access and apply new findings from many different fields.
This study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging (NIA), the Maximillian E. & Marion O. Hoffman Foundation, the RJG Foundation and the Michael J. Fox Foundation.
The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society, and publisher of the journal, Science (www.sciencemag.org) as well as Science Translational Medicine (www.sciencetranslationalmedicine.org) and Science Signaling (www.sciencesignaling.org). AAAS was founded in 1848, and includes some 262 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of 1 million. The non-profit AAAS (www.aaas.org) is open to all and fulfills its mission to “advance science and serve society” through initiatives in science policy; international programs; science education; and more. For the latest research news, log onto EurekAlert!, www.eurekalert.org, the premier science-news Web site, a service of AAAS. END
In Parkinson's disease, brain cells abandon mitochondria, researchers report
Study in Science Translational Medicine suggests new approaches to Parkinson's therapies
2010-10-08
ELSE PRESS RELEASES FROM THIS DATE:
Obese workers cost workplace more than insurance, absenteeism
2010-10-08
DURHAM, N.C. -- The cost of obesity among U.S. full-time employees is estimated to be $73.1 billion, according to a new study by a Duke University obesity researcher, published today in the Journal of Occupational and Environmental Medicine.
This is the first study to quantify the total value of lost job productivity as a result of health problems, which it finds is more costly than medical expenditures.
Led by Eric Finkelstein, deputy director for health services and systems research at Duke-National University of Singapore, the study quantified the per capita cost ...
Turtle, dugongs 'at risk under climate change'
2010-10-08
The "turtle and dugong capital of the world", the northern Great Barrier Reef (GBR) and Torres Strait region, faces increased pressure under climate change from human actions such as fishing, hunting, onshore development and pollution.
"Depletion of turtle and dugong numbers increases their vulnerability to other threats and lowers their ability to cope with climate change," Dr Mariana Fuentes of the ARC Centre of Excellence for Coral Reef Studies and James Cook University will tell the Coral Reef Symposium in Canberra today.
Dr Fuentes says that turtles in particular ...
New report: How will the affordable care act affect 15 million uninsured young adults?
2010-10-08
New York, NY, October 8, 2010—Young adults continue to represent one of the largest groups of Americans without health insurance, with nearly 15 million people aged 19-29 uninsured in 2009—an increase of more than 1 million over 2008, according to a Commonwealth Fund report released today. However, the Affordable Care Act (ACA) is poised to make a significant difference for this population, as up to 12.1 million could gain subsidized insurance once all of the law's provisions go into effect in 2014.
The report, Realizing Health Reform's Potential: Young Adults and the ...
Austin-Lehman Adventures Explores New Horizons in 2011 With Active Israel and Morocco Adventure Tours
2010-10-08
Austin-Lehman Adventures, Travel + Leisure's "World's Best" Operator Responds to Client Dream List Wishes - Breaks New Ground in Luxury Multisport Adventure to Israel and Morocco
The active travel company that set the adventure tour standard in Yellowstone National Park and then took their winning formula to Europe, Africa and beyond just released its 2011 catalog that includes two new groundbreaking tours in Israel and Morocco. Clients of Austin-Lehman Adventures have been asking for these "dream" destinations for years and the tour company responded with Israel & Jordan ...
Winner of FloorMall's Flooring Giveaway Announced
2010-10-08
A few months ago, in a joint promotional event with DearCrissy.com, FloorMall began its first ever Step Into Summer Flooring Sweepstakes. In the contest, FloorMall announced that they would be giving away 500 square feet of Mohawk hardwood flooring ( http://www.floormall.com/hardwood/ ) (a total value of over 1,200) to one DearCrissy.com blog reader. The prize flooring was hand-scraped, engineered Eucalyptus from Mohawk's Raschiato Series. The contest saw over a thousand different entries before its conclusion on July 30th. Sarah, a stay at home mother and blogger, was ...
Anderson Art Collective: Cubed...and Red Dotted
2010-10-08
On the heels of their invitation to the prestigious Red Dot Art Fair in Miami
(http://www.reddotfair.com) Anderson Art Collective (http://www.andersonartcollective.com) will open their next show Anderson Cubed with an artists' reception on Saturday, October 16th from 6-8pm at the gallery.
The show features contemporary oils by Sean Anderson, monumental oils and portraits by Benjamin Anderson and 3D mixed media by Ron Anderson.
"Despite the current economy, these artists have had an outstanding year. A solo show for Benjamin in Chelsea, NY, Sean's work collected ...
San Diego Ad Agency Offers Holiday Advertising Guarantee
2010-10-08
San Diego Ad Agency, Quantum Communications, is putting a new spin on the holiday rush this season. The agency is offering a guarantee that they will deliver any and all elements of an advertising or marketing campaign in time for the anticipated flurry of consumer spending over the holidays.
"Basically, it's a money back guarantee. If we do not deliver according to the deadline, we will refund 100% of the fees for our services" states Terry Vitiello, one of the founding partners of the 22 year-old San Diego Ad Agency.
"And because the agency will not assess any ...
Got an Old Furnace that Belongs in the Jurassic Period?
2010-10-08
Are you socking away money to heat your home this winter? Even though heating costs have steadily risen over the last five years, homeowners with "dinosaur" furnaces end up spending at least 30 percent more than homeowners with newer, energy efficient furnaces to heat their home each winter.
Winters Company, providers of plumbing, heating and air quality home services to thousands of residents in the greater Boston area, will be awarding a brand new $2500 energy efficient York heating system, fully-installed, along with one-year service contract to the person who can ...
Self-Service Private and Hybrid Cloud Coalition Gains Momentum
2010-10-08
newScale, rPath and Eucalyptus Systems, a coalition focused on bringing self-service private and hybrid clouds to the enterprise, today announced that it has formalized its name and launched a coalition website located at http://www.NREcloud.com.
The coalition, which is now called The NRE Alliance (NRE), was announced in August at VMworld 2010, where technologies from NRE members newScale and rPath won Best of VMworld 2010 awards in the "Private Cloud Computing" category.
Self-service private and hybrid cloud computing continues to generate a lot of interest as pressure ...
Lennar Virginia Launches Sales Event This Weekend
2010-10-08
Prospective buyers looking to get the deal of a lifetime are in luck because LennarâEUR s Virginia Division is offering a special 2.875 percent interest rate (3.09 percent APR) on new homes during their âEURœGreatest Home Sale EverâEUR event this weekend.
The event will take place on Saturday, October 9 through Sunday, October 10 at LennarâEUR s new home communities including MartinâEUR s Chase in Ashburn, Melody Landing At River Oaks in Woodbridge, Virginia Heritage at LeeâEUR s Parke in Fredericksburg and Colonial Heritage in Williamsburg.
âEURœWe are excited to ...
LAST 30 PRESS RELEASES:
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
More scrutiny of domestic fishing fleets at ports could help deter illegal fishing
Scientists transform plastic waste into efficient CO2 capture materials
Discovery of North America’s role in Asia’s monsoons offers new insights into climate change
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Researchers discover massive geo-hydrogen source to the west of the Mussau Trench
[Press-News.org] In Parkinson's disease, brain cells abandon mitochondria, researchers reportStudy in Science Translational Medicine suggests new approaches to Parkinson's therapies